Microbes, immunoregulation, and the gut

Gut

Volumn 54, Issue 3, 2005, Pages 317-320

  Rook, G A W ^a   Brunet, L R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; PREBIOTIC AGENT; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC DISEASE; BACTERIAL FLORA; BATH; COLITIS; CORRELATION ANALYSIS; CYTOKINE RELEASE; DRUG EFFECT; ENTERITIS; GENETIC DISORDER; HUMAN; HYGIENE; HYPOTHESIS; IMMUNOPHARMACOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE ABSORPTION; LACTOBACILLUS CASEI; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REMISSION; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TRICHURIS;

HUMANS; HYGIENE; IMMUNE SYSTEM DISEASES; INFLAMMATORY BOWEL DISEASES; INTESTINES; PROBIOTICS; T-LYMPHOCYTE SUBSETS;

EID: 14544295338     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.053785     Document Type: Review

References (40)

1. Rook GA, Adams V, Hunt J, et al. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Semin Immunopathol 2004;25:237-55.
2. Stene LC, Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet 2001;357:607.
3. Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:1567-75.
4. Viglietta V, Baecher-Allan C, Weiner HL, et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004;199:971-9.
5. Kriegel MA, Lohmann T, Gabler C, et al. Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 2004;199:1285-91.
6. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004;199:1679-88.
7. Makita S, Kanai T, Oshima S, et al. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004;173:3119-30.
8. Powrie F, Read S, Mottet C, et al. Control of immune pathology by regulatory T cells. Novartis Found Symp 2003;252:92-8.
9. Kraus TA, Toy L, Chan L, et al. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 2004;126:1771-8.
10. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-55.
11. Stanwell-Smith R, Bloomfield S. The hygiene hypothesis and its implications for home hygiene. Milano: NextHealth Srl, 2004.
12. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20.
13. Benn CS, Melbye M, Wohlfahrt J, et al. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ 2004;328:1223.
14. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001;358:1129-33.
15. Yazdanbakhsh M, Matricardi PM. Parasites and the hygiene hypothesis: regulating the immune system? Clin Rev Allergy Immunol 2004;26:15-24.
16. Bjorksten B, Naaber P, Sepp E, et al. The intestinal micraflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999;29:342-6.
17. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9.
18. Zuany-Amorim C, Sawicka E, Manlius C, et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002;8:625-9.
19. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001;107:531-4.
20. Camporota L, Corkhill A, Long H, et al. The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur Respir J 2003;21:287-93.
21. van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid crosstalk. Schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J Biol Chem 2002;277:48122-9.
22. Adams VC, Hunt J, Martinelli R, et al. Mycobacterium vaccae induces a population of pulmonary antigen presenting cells that have regulatory potential in allergic mice. Eur J Immunol 2004;34:631-8.
23. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004;126:520-8.
24. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
25. Kabesch M, Peters W, Carr D, et al. Association between polymorphisms in caspose recruitment domain containing protein 15 and allergy in two German populations. J Allergy Clin Immunol 2003;111:813-17.
26. Rook GA, Martinelli R, Brunet LR. Innate immune responses to mycobacteria and the downregulation of atopic responses. Curr Opin Allergy Clin Immunol 2003;3:337-42.
27. Groux H, O'Garra A, Bigler M, et al. A CD4+ subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997;389:737-42.
28. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003;299:1033-6.
29. Weinstock JV, Summers R, Elliott DE. Helminths and harmony. Gut 2004;53:7-9.
30. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-33.
31. Ghosh S, van Heel D, Playford RJ. Probiotics in inflammatory bowel disease: is it all gut flora modulation? Gut 2004;53:620-2.
32. Chapat L, Chemin K, Dubois B, et al. Lactobacillus casei reduces CD8(+) T cell-mediated skin inflammation. Eur J Immunol 2004;34:2520-8.
33. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002;168:171-8.
34. Asseman C, Powrie F. Interleukin 10 is a growth factor for a population of regulatory T cells. Gut 1998;42:157-8.
35. McCarthy J, O'Mahony L, O'Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003;52:975-80.
36. Sheil B, McCarthy J, O'Mahony L, et al. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 2004;53:694-700.
37. Tarkowski A, Lue C, Moldoveanu Z, et al. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses. J Immunol 1990;144:3770-8.
38. Kehrl JH, Fauci AS. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. J Clin Invest 1983;71:1032-40.
39. Kantele A, Savilahti E, Tiimonen H, et al. Cutaneous lymphocyte antigen expression on human effector B cells depends on the site and on the nature of antigen encounter. Eur J Immunol 2003;33:3275-83.
40. Fantini MC, Becker C, Monteleone G, et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004;172:5149-53.